Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversal of Rocuronium-induced Neuromuscular Block With Sugammadex in Heart Failure Patients

NCT01509651 is registered in ClinicalTrials.gov with Onze Lieve Vrouw Hospital as lead sponsor.

NCT NCT01509651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01509651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversal of Rocuronium-induced Neuromuscular Block With Sugammadex in Heart Failure Patients
Lead sponsor
Onze Lieve Vrouw Hospital
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2012
Completion date
April 30, 2012
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative neuromuscular block